187 related articles for article (PubMed ID: 38093605)
1. Evidence of direct interaction between cisplatin and the caspase-cleaved prostate apoptosis response-4 tumor suppressor.
Raut KK; Pandey S; Kharel G; Pascal SM
Protein Sci; 2024 Mar; 33(3):e4867. PubMed ID: 38093605
[TBL] [Abstract][Full Text] [Related]
2. Structural Analysis of the cl-Par-4 Tumor Suppressor as a Function of Ionic Environment.
Raut KK; Ponniah K; Pascal SM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807852
[TBL] [Abstract][Full Text] [Related]
3. Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation.
Chaudhry P; Singh M; Parent S; Asselin E
Mol Cell Biol; 2012 Feb; 32(4):826-39. PubMed ID: 22184067
[TBL] [Abstract][Full Text] [Related]
4. pH-Induced Folding of the Caspase-Cleaved Par-4 Tumor Suppressor: Evidence of Structure Outside of the Coiled Coil Domain.
Clark AM; Ponniah K; Warden MS; Raitt EM; Yawn AC; Pascal SM
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30518159
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the Conformational Stability of the cl-Par-4 Tumor Suppressor via Site-Directed Mutagenesis.
Pandey S; Raut KK; Clark AM; Baudin A; Djemri L; Libich DS; Ponniah K; Pascal SM
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189414
[TBL] [Abstract][Full Text] [Related]
6. Tetramer formation by the caspase-activated fragment of the Par-4 tumor suppressor.
Clark AM; Ponniah K; Warden MS; Raitt EM; Smith BG; Pascal SM
FEBS J; 2019 Oct; 286(20):4060-4073. PubMed ID: 31177609
[TBL] [Abstract][Full Text] [Related]
7. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
Palanichamy K; Sreejayan N; Ontko AC
J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
9. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
11. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new ultrasonic-assisted palladium oxide nanoparticles: an in vitro evaluation on cytotoxicity and DNA/BSA binding properties.
Sorinezami Z; Mansouri-Torshizi H; Aminzadeh M; Ghahghaei A; Jamgohari N; Heidari Majd M
J Biomol Struct Dyn; 2019 Oct; 37(16):4238-4250. PubMed ID: 30600777
[TBL] [Abstract][Full Text] [Related]
13. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
14. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
Nguyen DM; Yeow WS; Ziauddin MF; Baras A; Tsai W; Reddy RM; Chua A; Cole GW; Schrump DS
Cancer J; 2006; 12(4):257-73. PubMed ID: 16925970
[TBL] [Abstract][Full Text] [Related]
15. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of Par-4 combined with cisplatin on human Wilms' tumor cells.
Wang J; Li Y; Ma F; Zhou H; Ding R; Lu B; Zou L; Li J; Lu R
Tumour Biol; 2017 Jul; 39(7):1010428317716689. PubMed ID: 28720068
[TBL] [Abstract][Full Text] [Related]
17. The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer.
Kaku Y; Tsuchiya A; Kanno T; Nakao S; Shimizu T; Tanaka A; Nishizaki T
Cancer Chemother Pharmacol; 2015 Mar; 75(3):527-35. PubMed ID: 25567349
[TBL] [Abstract][Full Text] [Related]
18. Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis.
Zisman A; Ng CP; Pantuck AJ; Bonavida B; Belldegrun AS
J Immunother; 2001; 24(6):459-71. PubMed ID: 11759069
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
Li QQ; Wang G; Reed E; Huang L; Cuff CF
Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):868-76. PubMed ID: 22545969
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
